GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DA) » Definitions » PB Ratio

Melodiol Global Health (ASX:ME1DA) PB Ratio

: (As of Today)
View and export this data going back to 2016. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-23), Melodiol Global Health's share price is A$0.013. Melodiol Global Health's Book Value per Share for the quarter that ended in Dec. 2023 was A$-0.02. Hence, Melodiol Global Health's PB Ratio of today is .

The historical rank and industry rank for Melodiol Global Health's PB Ratio or its related term are showing as below:

During the past 8 years, Melodiol Global Health's highest PB Ratio was 23.95. The lowest was 0.16. And the median was 2.89.

ASX:ME1DA's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.91
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Melodiol Global Health's average Book Value Per Share Growth Rate was -107.00% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Melodiol Global Health was 21.80% per year. The lowest was -57.10% per year. And the median was -47.70% per year.

Back to Basics: PB Ratio


Melodiol Global Health PB Ratio Historical Data

The historical data trend for Melodiol Global Health's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Premium Member Only Premium Member Only Premium Member Only 1.23 11.88 3.62 1.65 -

Melodiol Global Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 1.64 1.65 2.09 -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health PB Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's PB Ratio distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's PB Ratio falls into.



Melodiol Global Health PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Melodiol Global Health's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.013/-0.017
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Melodiol Global Health  (ASX:ME1DA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Melodiol Global Health PB Ratio Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health (ASX:ME1DA) Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DA) Headlines

No Headlines